TAMs in RCC first caught the sight of researchers about 10 years ago because of the finding that high TAMs frequency and CD163 (one of the TAM surface markers) infiltration occurred in the cases with poorer prognosis data, when researchers cocultured RCC cell lines with polarized type II macrophages with CD163+ (39). Here, CD163 is linked to renal cell carcinoma.